5-138352858-GGCCTCA-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM4BP6BS2
The NM_016604.4(KDM3B):c.69_74delAGCCTC(p.Ala24_Ser25del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000211 in 1,376,412 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.000020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000021 ( 0 hom. )
Consequence
KDM3B
NM_016604.4 disruptive_inframe_deletion
NM_016604.4 disruptive_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 3.02
Genes affected
KDM3B (HGNC:1337): (lysine demethylase 3B) Predicted to enable chromatin DNA binding activity; histone H3-methyl-lysine-9 demethylase activity; and transcription coregulator activity. Predicted to be involved in histone H3-K9 demethylation and regulation of transcription by RNA polymerase II. Located in nucleoplasm. Biomarker of acute lymphoblastic leukemia; breast cancer; colorectal cancer; and lung non-small cell carcinoma. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -3 ACMG points.
PM4
Nonframeshift variant in NON repetitive region in NM_016604.4.
BP6
Variant 5-138352858-GGCCTCA-G is Benign according to our data. Variant chr5-138352858-GGCCTCA-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 2351648.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=1}.
BS2
High AC in GnomAdExome4 at 26 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KDM3B | NM_016604.4 | c.69_74delAGCCTC | p.Ala24_Ser25del | disruptive_inframe_deletion | 1/24 | ENST00000314358.10 | NP_057688.3 | |
KDM3B | XM_005272018.5 | c.69_74delAGCCTC | p.Ala24_Ser25del | disruptive_inframe_deletion | 1/23 | XP_005272075.1 | ||
KDM3B | XM_047417313.1 | c.-980_-975delAGCCTC | 5_prime_UTR_variant | 1/25 | XP_047273269.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KDM3B | ENST00000314358.10 | c.69_74delAGCCTC | p.Ala24_Ser25del | disruptive_inframe_deletion | 1/24 | 1 | NM_016604.4 | ENSP00000326563.5 |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151484Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
3
AN:
151484
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000212 AC: 26AN: 1224820Hom.: 0 AF XY: 0.0000232 AC XY: 14AN XY: 602548
GnomAD4 exome
AF:
AC:
26
AN:
1224820
Hom.:
AF XY:
AC XY:
14
AN XY:
602548
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000198 AC: 3AN: 151592Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74092
GnomAD4 genome
AF:
AC:
3
AN:
151592
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
74092
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 08, 2021 | The c.69_74delAGCCTC (p.S27_A28del) alteration is located in exon 1 (coding exon 1) of the KDM3B gene. This alteration consists of an in-frame deletion of 6 nucleotides between nucleotide positions c.69 and c.74, resulting in the deletion of 2 residues. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2023 | KDM3B: BS2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at